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R850instability is merely a side effect of
optimizing the mechanical parameters
of the cell for otherwise successful
cytokinesis. However, it is also
possible that the small oscillations
observed in successfully dividing cells
are beneficial. For example, dividing
cells must ensure the proper
partitioning of cellular components,
which is especially critical for low
copy number proteins [19]. Oscillations
may thus facilitate thorough mixing
of the cytoplasm. Alternatively,
oscillations could help the cell decide
where exactly to put the division plane.
Finally, since spindle microtubules
can be anchored directly in the
cytoplasm [20], cytoplasmic
oscillations may have interesting
implications for the mechanics of the
anaphase spindle.
In sum, the new study from Sedzinski
et al. [6] greatly expands our
knowledge of the mechanics of cell
division and beautifully demonstrates
the power of combining quantitative
cell biology and computational
modeling.
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Germ-Cell TheoryThe exact cellular origin of embryonic stem cells remains elusive. Now a new
study provides compelling evidence that embryonic stem cells, established
under conventional culture conditions, originate from a transient germ-cell
state.Konrad Hochedlinger1,2,3
The study of pluripotent cell lines has
captivated researchers for the past five
decades because of their enormous
developmental and therapeutic
potentials [1]. Historically, pluripotent
stem cell lines were derived from
teratocarcinomas — tumors of germ
cell origin, giving rise to so-called
embryonic carcinoma cells (ECCs).
This discovery subsequently led to the
derivation of embryonic stem cells
(ESCs) from explanted preimplantation
mouse embryos, and of embryonic
germ cells (EGCs) from culturedprimordial germ cells (PGCs). Despite
their different origins, ESCs, EGCs and
ECCs are molecularly and functionally
very similar. These observations raise
the important question whether ESCs,
like ECCs and EGCs, might be derived
from early germ cells [2]. Identifying
the origins of ESCs is key for
understanding the basic biology of
existing pluripotent cell lines, as well
as for ongoing efforts to derive new
ESC and iPSC lines from species and
cell types that have thus far been
refractory to stem cell isolation.
While it has been assumed that ESCs
are the direct product of cells from thepluripotent inner cell mass (ICM) of the
blastocyst, several observations are
consistent with the idea that they may
in fact originate from primitive germ
cells. For example, expression of the
essential epiblast and germ-cell gene
Oct4 becomes confined to a few cells in
explanted ICM outgrowths [3], which is
reminiscent of the emergence of rare
Oct4-expressing PGCs from proximal
epiblast cells soon after implantation.
In agreement, only a small fraction
of singly plated epiblast cells yields
ESC colonies in conventional culture
conditions, suggesting that these
may represent rare germ-cell
precursors [4]. Moreover, PGCs are
the only postimplantation cell type
that continues to express several
pluripotency genes such as Oct4,
Nanog and Sox2 [5]. In this issue of
Current Biology, Zwaka and colleagues
[6] revisit this important question by
deriving ESCs from blastocysts in
which the nascent germ-cell lineage
has been genetically tagged.
Blastocyst
explantation
Serum
Lif
2i
Naive
ESCs
Selection of Blimp1+
outgrowth cells 
Most mouse strains
refractory to ESC
derivation 
Maintenance of
epiblast state 
Facilitates derivation
of ESC lines from
non-permissive strains
and rats 
PGC-like
state
Current Biology
Transient activation of
germ-cell program 
Suppression of 
germ-cell program 
Figure 1. The germ-cell program and ESC derivation.
This scheme summarizes the two different approaches to ESC derivation in serum/Lif and 2i,
respectively, and their effect on transient activation of a germ-cell program.
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To genetically mark germ cells,
the authors utilized an elegant
fate mapping system that
permanently activates a red
fluorescent RFP-reporter gene
(ROSA26-loxSTOPlox (lsl)-RFP) in
most cells that express the germ-cell
specification factor Blimp1 and their
progeny (Blimp1-Cre). While no
RFP-positive cells were detectable
in blastocysts isolated from double
transgenic mice, rare RFP-positive
cells emerged after their explantation
and amplified when cultured in regular
ESC-conditions (serum and leukemia
inhibitory factor (Lif)). Single-cell
expression analysis of RFP-positive vs.
RFP-negative cells from early ICM
outgrowths confirmed that other
germ-cell markers, such as Stella and
Prdm14, had also been activated in
those cells. Collectively, these findings
suggested that explanted blastocysts
transiently activate a transcriptional
program specific for PGCs.
To assess whether Blimp1-positive
blastocyst-derived cells are functional
germ cells, the authors transplanted
Blimp1-positive ICM outgrowth cells
into E8.5 germ-cell-deficient embryos.
Indeed, Blimp1-positive cells migrated
to the genital ridges and upregulated
the germ line maturation marker Mvh,
indicating that Blimp1-positive cells
have migratory and differentiation
potential akin to that of endogenous
PGCs.
When blastocysts containing
Blimp1-Cre and the RFP reporter were
put in culture containing serum and Lif
for ESC derivation, around 80% of the
resultant ESC lines were RFP-positive,
indicating that transit through a
germ-cell-like state may be obligatory
for ESC derivation. In support of this
interpretation, Zwaka and colleagues
[6] showed that the sorting and
explantation of RFP-positive cells from
early ICM outgrowths gives rise to ESC
lines nine times more efficiently than
bulk ICM cells do. Taken together,
these results show that activation of
Blimp1 predicts successful ESC
derivation from blastocysts.
In an effort to genetically test
whether activation of a germ-cell
program is required for ESC derivation,
the authors attempted to derive ESC
lines from blastocysts deficient for
Blimp1. Loss of Blimp1 in development
results in defects in PGC migration and
specification. Surprisingly, however,
Blimp1-null ESCs were received atexpected Mendelian ratios from
heterozygous mutant intercrosses.
While this result clearly documents
that Blimp1 is not required for ESC
derivation, it does not unequivocally
show that transit through a PGC state
per se is not essential as Blimp1
deficiency does not entirely deplete
PGCs in vivo [7]. It should be
informative to assess whether EGCs
can be derived from the residual PGCs
present in Blimp1–/– embryos.
Bypassing the Germ-Cell Program
ESCs have originally been derived and
maintained in media containing serum
or Bmp4 and Lif. More recently, Austin
Smith’s lab has described more
defined culture conditions, which
comprise two chemical inhibitors of the
Fgf/Erk and Gsk3 kinases, — dubbed
‘2i’ — that are thought to counteract
ESC differentiation [8]. Importantly,
2i media gives rise to ESC lines more
reproducibly and efficiently than
serum/Lif culture with almost every
ICM cell acquiring the potential to
give rise to an ESC line [9]. In further
contrast to serum/Lif, 2i facilitates the
derivation of ESC lines from mouse
strains that have previously been
considered recalcitrant to ESC
isolation [8] as well as from rats [10].
Intriguingly, the majority of ESC lines
recovered by Zwaka and colleagues
[6] in 2i from blastocysts carrying
Blimp1-Cre and the RFP reporter
were RFP-negative. This unexpected
result suggests that blocking Fgf/Erkand/or Gsk3 signaling may suppress
a germ-cell program and directly
endow epiblast cells with self-renewal
potential, thus circumventing the need
to pass through a germ-cell state.
Taken together, these observations
demonstrate that mouse ESC
derivation can be achieved via different
routes: through a germ-cell-like
intermediate in serum/Lif and directly
from epiblast in 2i conditions [9]
(Figure 1).
The finding that a pluripotent ground
state can be attained from epiblast
cells via different routes, depending on
the choice of culture conditions, may
explain the previous failure to derive
ESC lines from certain mouse strains
and other animal species; that is,
epiblasts from non-permissive mouse
strains, like NOD, or other rodent
species, such as rats, may have been
unsuccessful in Lif/Bmp because no
germ-cell program was activated. 2i
treatment presumably bypasses this
requirement by directly stabilizing
a self-renewing epiblast state. This
notion could be easily tested by
assessing Blimp1 activation in ICM
outgrowths from NOD blastocysts
and rats upon exposure to Lif/Bmp.
If induction of pluripotency by defined
transcription factors follows similar
principles as ESC derivation, one might
expect that somatic cells from some
strains of mice and other species
should also be differentially amenable
to reprogramming into induced
pluripotent stem cells (iPSCs) [11]. In
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[12] observed that reprogramming of
fibroblasts from a 129/MF1 hybrid
strain of mice gives rise mostly
to partially reprogrammed iPSCs
that rarely progress to pluripotency
unless treated with 2i. Similarly, the
establishment of rat iPSCs requires 2i
culture.
What consequences might these
findings have for human ESC/iPSC
research? Human ESCs are
fundamentally different from mouse
ESCs in that they require bFgf and
Activin A for their stable propagation
[1]. Interestingly, exposure of mouse
blastocysts, ESCs or postimplantation
embryos to bFgf and Activin A gives
rise to so-called epiblast stem cells
(EpiSCs) [13,14], which are very similar
to human ESCs and seem to represent
a developmentally more advanced or
‘primed’ state compared with the more
primitive or ‘naive’ state ofmouse ESCs
[15]. The findings by Chu et al. [6] thus
raise the interesting possibility that
progression of epiblast cells towards
a germ-cell fate, either by enforced
expression of certain transcription
factors [1,9] or by exposure of cells
to germ-cell-inducing cytokines, might
be sufficient to derive stable naive
ESC/iPSC lines in humans and other
species. Recent exciting progress inidentifying molecules that coax
pluripotent cells into germ cellsmay aid
in these efforts [16].References
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Mitochondrial Uncoupling
and EngulfmentClearance of apoptotic cells by phagocytes avoids triggering an inflammatory
response. A new study reveals that phagocytes dissipate their mitochondrial
proton electrochemical gradient to allow for the ingestion of more apoptotic
corpses. Mitochondria are therefore involved in all aspects of apoptosis, from
its activation through to the phagocytosis of dead cells.Grazia M. Cereghetti
and Luca Scorrano
Sustained cell proliferation during
development, tissue renewal or in the
course of the immune response is
accompanied by the production of
excess or damaged cells that die by
apoptosis. The accumulation of these
cells may lead to tissue damage and
inflammation: specialized systems
therefore efficiently remove them [1,2].Phagocytes are deputed to the
clearance of apoptotic cells and are
able to engulf multiple cells in order to
adapt their ‘cleaning efficiency’ to the
rate of apoptotic cell accumulation.
In recent years, some of the crucial
steps in the phagocytosis of apoptotic
cells, as well as the principal players
in the phagocytic process, have been
elucidated [3,4]. Dying cells release
signals to attract the motile
phagocytes. The two cells makephysical contact via markers that are
released from the apoptotic cell and
bind to receptors on the phagocyte,
inducing a signaling cascade that
prepares the phagocyte membrane
for the internalization of the dead cell.
Several molecules are involved in
engulfment by phagocytes, including:
brain angiogenesis inhibitor 1 (BAI1),
a transmembrane protein highly
expressed in the brain; Rac GTPases,
which remodel the cytoskeleton;
ELMO, an evolutionarily conserved
cytoplasmic engulfment protein; and
the unconventional guanine nucleotide
exchange factor and Rho GTPase
activator Dock180 [5]. Despite our
knowledge of some key molecular
steps in the engulfment cascade,
how a single phagocyte can serially
internalize many apoptotic cells is
unclear. Park et al. [6] have now
shown, in a recent issue of Nature,
that serial internalization of apoptotic
cells unexpectedly depends on
